Pengrong Gao
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Luteolin Enhances Endothelial Barrier Function and Attenuates Myocardial Ischemia-Reperfusion Injury via FOXP1-NLRP3 Pathway.
Journal: International journal of molecular sciences
Published: December 01, 2025
Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3.
Journal: Journal of ethnopharmacology
Published: January 28, 2023
Exploring the Mechanism of Si-miao-yong-an Decoction in the Treatment of Coronary Heart Disease based on Network Pharmacology and Experimental Verification.
Journal: Combinatorial chemistry & high throughput screening
Published: October 24, 2022
Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca2+-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-κB pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 20, 2022
β-elemene blocks lipid-induced inflammatory pathways via PPARβ activation in heart failure.
Journal: European journal of pharmacology
Published: May 25, 2021
Corrigendum to "Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway".
Journal: BioMed research international
Published: June 08, 2020
Qishen granules exerts cardioprotective effects on rats with heart failure via regulating fatty acid and glucose metabolism.
Journal: Chinese medicine
Published: October 13, 2019
Ginsenoside Rb3 regulates energy metabolism and apoptosis in cardiomyocytes via activating PPARα pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 16, 2019
Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway.
Journal: BioMed research international
Published: March 27, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026